Publications by authors named "J A Cardillo"
Background: Accurate assessment of intravascular volume is critical for precise fluid prescription. In people, bedside or point of care ultrasound is used to measure the inferior vena cava, with or without paired aortic measurement, to estimate intravascular volume.
Objective: To determine if point of care ultrasound measurement of the caudal vena cava (CVC) diameter or the CVC diameter to the abdominal aorta (Ao) diameter (CVC:Ao) at the paralumbar view are associated with changes in intravascular volume, mean arterial pressure (MAP), or cardiac output in normovolemic and hypovolemic dogs.
Article Synopsis
- The study aimed to examine the impact of a combined laser treatment technique (SWG) and ranibizumab injections on key eye health metrics in patients with diabetic macular edema (DME).
- A total of 45 eyes from 33 patients received this treatment over 12 months, monitoring changes in central subfield thickness (CSFT), visual acuity (BCVA), and macular sensitivity through regular examinations.
- Results showed significant improvements in CSFT, BCVA, and macular sensitivity after one year, with no adverse effects reported from the treatments administered.
Objective: To investigate the effects of hemorrhagic shock and fresh whole blood resuscitation on the microcirculation and endothelial glycocalyx using sidestream dark field (SDF) imaging and plasma biomarkers.
Animals: 8 purpose-bred dogs.
Methods: Pressure-targeted hemorrhagic shock was induced in anesthetized dogs.
Article Synopsis
- The study focuses on dome-shaped macula (DSM), a condition causing visual impairment due to sub-foveal serous retinal detachment (SRD), and evaluates the effects of a new laser treatment method on affected patients.
- It included seven patients with SRD and assessed various eye health indicators before and after treatment, with an average follow-up of about 13 months.
- Results showed a significant reduction in central subfield thickness and improvement in visual acuity post-treatment, with no reported adverse effects, indicating the treatment's effectiveness for resolving SRD due to DSM.
Background: Diabetic macular edema (DME) is the main cause of visual loss in diabetic patients. Despite the use of anti-VEGF therapy as first-line treatment, there are many patients whose response to treatment is poor or transient at best. Sophisticated laser techniques have emerged aiming at low-intensity retinal damage, avoiding excessive heat that causes tissue necrosis and related collateral effects.
View Article and Find Full Text PDF